3-(3,5-dichlorophenyl)-2,4-dioxo-N-propan-2-ylimidazolidine-1-carboxamide

3-(3,5-Dichlorophenyl)-N-(1-methylethyl)-2,4-dioxo-1-imidazolidinecarboxamide; LC-ESI-QFT; MS2; CE: 120%; R=15000; [M+H]+

3-(3,5-Dichlorophenyl)-N-(1-methylethyl)-2,4-dioxo-1-imidazolidinecarboxamide; LC-ESI-QFT; MS2; CE: 15%; R=15000; [M+H]+

3-(3,5-Dichlorophenyl)-N-(1-methylethyl)-2,4-dioxo-1-imidazolidinecarboxamide; LC-ESI-QFT; MS2; CE: 150%; R=15000; [M+H]+

3-(3,5-Dichlorophenyl)-N-(1-methylethyl)-2,4-dioxo-1-imidazolidinecarboxamide; LC-ESI-QFT; MS2; CE: 180%; R=15000; [M+H]+

3-(3,5-Dichlorophenyl)-N-(1-methylethyl)-2,4-dioxo-1-imidazolidinecarboxamide; LC-ESI-QFT; MS2; CE: 30%; R=15000; [M+H]+

3-(3,5-Dichlorophenyl)-N-(1-methylethyl)-2,4-dioxo-1-imidazolidinecarboxamide; LC-ESI-QFT; MS2; CE: 45%; R=15000; [M+H]+

3-(3,5-Dichlorophenyl)-N-(1-methylethyl)-2,4-dioxo-1-imidazolidinecarboxamide; LC-ESI-QFT; MS2; CE: 60%; R=15000; [M+H]+

3-(3,5-Dichlorophenyl)-N-(1-methylethyl)-2,4-dioxo-1-imidazolidinecarboxamide; LC-ESI-QFT; MS2; CE: 75%; R=15000; [M+H]+

3-(3,5-Dichlorophenyl)-N-(1-methylethyl)-2,4-dioxo-1-imidazolidinecarboxamide; LC-ESI-QFT; MS2; CE: 90%; R=15000; [M+H]+

3-(3,5-DICHLOROPHENYL)-N-ISOPROPYL-2,4-DIOXO-1-IMIDAZOLIDINECARBOXAMIDE; EI-B; MS

3-(3,5-DICHLOROPHENYL)-N-ISOPROPYL-2,4-DIOXOIMIDAZOLIDINE-1-CARBOXAMIDE; EI-B; MS

IPRODIONE; EI-B; MS

Iprodione; GC-EI-Q; MS; Positive; M+*

Iprodione; LC-ESI-QFT; MS2; CE: 15; R=35000; [M+H]+

Iprodione; LC-ESI-QFT; MS2; CE: 30; R=35000; [M+H]+

Iprodione; LC-ESI-QFT; MS2; CE: 45; R=35000; [M+H]+

Iprodione; LC-ESI-QFT; MS2; CE: 60; R=35000; [M+H]+

Iprodione; LC-ESI-QFT; MS2; CE: 75; R=35000; [M+H]+

Iprodione; LC-ESI-QFT; MS2; CE: 90; R=35000; [M+H]+